E-LIB Suche - Ergebnisse für: Genge, A

1

D.2 Cost-effectiveness analysis of efgartigimod vs chronic ..:

Siddiqi, Z ; Genge, A ; Qi, C...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51 (2024) s1 - p. S9-S9 , 2024

Link: https://doi.org/10.1017/..

2

P.054 Long-term safety and efficacy of zilucoplan in myasth..:

Genge, A ; Howard Jr., JF ; Freimer, M...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51 (2024) s1 - p. S30-S31 , 2024

Link: https://doi.org/10.1017/..

3

P.055 Corticosteroid dose tapering in patients with general..:

Genge, A ; Hewamadduma, C ; Freimer, M...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51 (2024) s1 - p. S31-S31 , 2024

Link: https://doi.org/10.1017/..

4

P273 Long-term safety, efficacy & self-injection satisfacti..:

Farmakidis, C. ; Leite, M. ; Bresch, S....
Neuromuscular Disorders. 33 (2023) - p. S178 , 2023

Link: https://doi.org/10.1016/..

5

P.043 Long-term safety, tolerability, and efficacy of efgar..:

Genge, A ; Pasnoor, M ; Bril, V...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50 (2023) s2 - p. S69-S69 , 2023

Link: https://doi.org/10.1017/..

6

P76 The Canadian neuromuscular disease registry: a national..:

Sobey, M. ; Hodgkinson, V. ; Westbury, G....
Neuromuscular Disorders. 33 (2023) - p. S135-S136 , 2023

Link: https://doi.org/10.1016/..

7

P.046 Real-world survival effectiveness of edaravone in amy..:

Abrahao, A ; Vyas, MV ; Parks, A...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50 (2023) s2 - p. S70-S70 , 2023

Link: https://doi.org/10.1017/..

8

MOTOR NEURON DISORDERS AND NEUROPATHIES:

Hodgkinson-Brechenmacher, V. ; Lounsberry, J. ; Abrahao, A....
Neuromuscular Disorders. 31 (2021) - p. S123 , 2021

Link: https://doi.org/10.1016/..

9

The Canadian Neuromuscular Disease Registry 2010–2019: A De..:

Hodgkinson, V. ; Lounsberry, J. ; M'Dahoma, S....
Journal of Neuromuscular Diseases. 8 (2021) 1 - p. 53-61 , 2021

Link: https://doi.org/10.3233/..

10

GP.2 Changes in Leptin, CCL16 and sTNF-RII as a distinctive..:

Picher-Martel, V ; Boutej, H ; Cordeau, P...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48 (2021) s3 - p. S12-S12 , 2021

Link: https://doi.org/10.1017/..

11

FSHD / OPMD / MYOTONIC DYSTROPHY:

Mellion, M. ; Tawil, R. ; Ronco, L....
Neuromuscular Disorders. 30 (2020) - p. S112 , 2020

Link: https://doi.org/10.1016/..

12

P.026 Response to eculizumab in patients with myasthenia gr..:

Genge, A ; Jacob, S ; Murai, H...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 46 (2019) s1 - p. S20-S21 , 2019

Link: https://doi.org/10.1017/..

13

FSHD / OPMD / EDMD / DMI:

Statland, J. ; Bravver, E. ; Karam, C....
Neuromuscular Disorders. 28 (2018) - p. S140 , 2018

Link: https://doi.org/10.1016/..

14

The feasibility of rare neuromuscular disease trials: Prese..:

Genge, A. ; Campbell, N.
Neuromuscular Disorders. 25 (2015) - p. S241 , 2015

Link: https://doi.org/10.1016/..

15

Study design of a prospective natural history study in spor..:

Houston, P. ; Lowes, L. ; Greenberg, S....
Neuromuscular Disorders. 25 (2015) - p. S238 , 2015

Link: https://doi.org/10.1016/..